News

Medicago has signed a memorandum of understanding (MOU) with Ajanta Pharma, to negotiate an agreement to commercialize Medicago’s pandemic and seasonal influenza VLP-based vaccines in India and other

Bristol-Myers Squibb has reported that the US District Court for the Southern District of New York has granted preliminary approval of settlement of Sampson v. Robinson, et al.,

The Medicines Company has withdrawn the European marketing authorization application (MAA) for the 200mg, 3-7 day daily dose therapy of oritavancin. Oritavancin is an investigational antibiotic drug candidate

A study conducted by HerbalScience has reported that they have identified the key chemical components in elderberry, cinnamon, and green tea extracts that bind to the HIV viruses

Skystar has initiated early-stage field experiments of its proprietary – Methionine Enkephalin (Met-Enk) powder. Met-Enk is designed to boost the immune system of livestock, which helps animals’ immune

MicroPhage has launched its multi-site clinical trial to support a FDA premarket notification 510(k). The platform has been developed to rapidly identify bacterial infections and determine antibiotic susceptibility

Bristol-Myers Squibb has extended its previously announced cash tender offer, through its wholly-owned subsidiary Puma Acquisition Corporation (Puma), to purchase all outstanding shares of common stock of Medarex

INVISTA has signed a technology licensing agreement with Chongqing Jian-Feng Industrial Group, to license its BDO and PTMEG manufacturing technologies to the Chinese company. Jian-Feng is investing RMB2

ZymoGenetics has reported the submission of a Citizen Petition to the FDA, requesting the removal of Thrombin-JMI Thrombin, topical (bovine origin) from the market, in the interest of